Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.

Akira Horikoshi,Noriyoshi Iriyama,Yukio Hirabayashi,Hitomi Kodaira,Yoshihiro Matsukawa,Yoshihito Uchino,Hiromichi Takahashi,Yoshihiro Hatta,Jin Takeuchi,Sumiko Kobayashi,Katsuhiro Miura

Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.

2013

Akira Horikoshi
Noriyoshi Iriyama
Yukio Hirabayashi
Hitomi Kodaira
Yoshihiro Matsukawa
Yoshihito Uchino
Hiromichi Takahashi
Yoshihiro Hatta
Jin Takeuchi
Sumiko Kobayashi
Katsuhiro Miura

Background: Elderly acute myeloid leukemia (AML) patients and patients with higher-risk myelodysplastic syndromes (MDS) have a much poorer prognosis than younger

Keywords:

Immunology
Biology
Oncology
Etoposide
Cytarabine ocfosfate
Myeloid leukemia
Myelodysplastic syndromes
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations